MPN News From ASH 2016: An Update From Dr. Srdan Verstovsek


Dr. Srdan Verstovsek of MD Anderson Cancer Center shares a comprehensive overview of the treatments for myeloproliferative neoplasms (MPNs) being discussed at ASH 2016.  Listen as Dr. Verstovsek discusses the results from COMFORT I & II studies, research around interferon therapy for polycythemia vera (PV), JAK inhibitor studies, new therapies to combat anemia, as well as some of the newer therapies that we will learn more about in 2017.

Sign in or Register to view comments.